Drug intelligence / Profile preview

difenoxin

Development stage
Unknown
Lead developer
Silag
Modality
Small Molecules
Administration
Oral
01

Overview

Difenoxin is a synthetic opioid antidiarrheal agent and the principal active metabolite of diphenoxylate. It is used primarily as an adjunct for the management of acute nonspecific diarrhea and acute exacerbations of chronic functional diarrhea. Difenoxin acts mainly in the periphery by activating opioid receptors in the intestine, thereby inhibiting peristalsis and slowing intestinal transit time. This results in decreased frequency and liquidity of bowel movements. While structurally related to meperidine, difenoxin has minimal central nervous system effects at therapeutic doses but can cross the blood-brain barrier at higher doses to produce weak sedative or analgesic effects. To deter abuse, it is commonly formulated with atropine (as in Motofen), which induces unpleasant side effects if taken in excess[1][2][4][5]. Difenoxin alone is classified as a Schedule I controlled substance in the US; when combined with atropine, it is Schedule IV.

Brand names
Motofen
Other names
difenoxindiphenoxylic acid
02

Targets

DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on difenoxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on difenoxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call